Final Analysis of the Randomised UK MRA Myeloma XI+ Trial Examining Krdc (carfilzomib, Lenalidomide, Dexamethasone and Cyclophosphamide) As Induction Therapy for Newly Diagnosed Multiple Myeloma Patients
Blood(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要